Illumina announced that it is acquiring NextBio,a leading California based bioinformatics company for analyzing and aggregating Complex Genomic Data. Announcing the acquisition of NextBio via its press release, Illumina said the acquisition will strengthen Illumina’s informatics portfolio and help accelerating the adoption of Next-Generation Sequencing in the market.
NextBio was co-founded by Saeid Akhtari, Ilya Kupershmidt and Mostafa Ronaghi in 2004. NextBio launched a platform that lets biologists/clinicians to search for genes, proteins, compounds in a variety of contexts using public and proprietary genomic data. NextBio’s current big data platforms are used by a number of commercial and academic institutions including Pfizer, Novartis, Genzyme, and Eli Lilly.
Upon the acquisition, Illumina will integrate NextBio into a new Enterprise Informatics business led by Nick Naclerio, SVP of Corporate and Venture Development and General Manager of Enterprise Informatics. NextBio co-founder Ilya Kupershmidt and Chief Technology Officer Satnam Alag will be part of the new unit and provide scientific and technical leadership. In the press release, Jay Flatley, President and CEO of Illumina said that
This agreement with NextBio demonstrates Illumina’s unwavering commitment to drive the adoption of sequencing in new markets and vastly improve the genomic information workflow. NextBio enables the classification and aggregation of phenotypic and clinical data within a single environment and allows analysis of that data at unprecedented speed and scale. The combination of Illumina’s BaseSpace cloud computing environment for next-generation sequencing with NextBio’s platform for integrating patient data will allow us to deliver solutions that seamlessly integrate the entire workflow from sample to result.
NextBio is Illumina’s fourth acquisition for the year 2013. Illumina started the year off by acquiring Verinata Health and Moleculo in January 2013. Then in July, Illumina acquired Advanced Liquid Logic in July 2013.
Learn more about NextBio company’s origin from BioIT piece written by Kevin Davies in 2006.